Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

By Design

With antibody-drug conjugates breaking new ground in oncology therapeutics, Trevor Hallam, Jeremy Bender and William Newell from Sutro Biopharma look at enhancements to the next generation of products.

Trevor Hallam, Jeremy Bender and William Newell, Sutro Biopharma (June 2014)

Keywords: Monoclonal antibodies, Site-specific conjugation, Non-natural amino acids

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |